Daniel Davies Whittaker, a Director, acquired 100,000 Common Shares on an indirect ownership basis for registered holder Birchpoint Holdings Inc. at a price of $1.000 through a prospectus or prospectus exempt offering on December 15th, 2020. The insider also acquired 50,000 Warrants with an exercise price of $1.250 for 24 months. This represents a $100,000 investment into the company's shares and an account share holdings change of 5.5%.
Sona Nanotech is in the Medical Equipment, Supplies & Distribution Sub Industry Group under the Healthcare Sector.
Sona Nanotech Inc. is a nanotechnology life sciences company. The principal business is the development and application of its technology for use in multiplex diagnostic testing platforms. The Company offers a suite of products and services for multiple applications, including custom conjugation, lateral flow test development, lateral flow test production, point of care diagnostics, drug delivery, photo-thermal therapy and cell imaging. The Company's products include Lateral flow. Its Lateral flow is a technology and a paper-based diagnostic test used to confirm the presence or absence of a target analyte in a sample without the need for specialist lab equipment. Lateral flow tests are used in various sectors, which include animal and veterinary health, food and drink, environmental testing, agricultural testing, and drugs of abuse.
No Comments